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Abstract
A new autoantibody activity, which is almost 100% specific for rheumatoid arthritis (RA), has
been found. The essential part of the B-cell epitope is a modified form of arginine (ie
citrulline). The conversion of protein-contained arginine to citrulline is an enzymatic process
that is carried out by peptidylarginine deiminase (PAD), an enzyme that appears to be
hormonally controlled. Because of its remarkable specificity, citrullination and related
processes might open new possibilities for studying the aetiology of RA.
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Introduction
In many systemic immunoinflammatory diseases the pres-
ence of the so-called antinuclear autoantibodies is a domi-
nant serological feature [1–3]. Although many
autoantigens are ubiquitously expressed, often they are
only autoantigenic in certain autoimmune diseases. A
growing number of studies seem to indicate that post-
translational modifications could be responsible for the
initial triggering of autoimmunity and the breaking of toler-
ance (for review [4]). During the past 5 years much atten-
tion has been paid to the fact that many environmental
factors known to be involved in the onset of autoimmunity
lead to enhanced apoptosis, and to the finding that during
apoptosis many autoantigens are uniquely modified. Such
modifications on self-proteins may uncover cryptic epi-
topes and/or create novel epitopes to which no tolerance
exists, and could therefore provoke an autoimmune
response in susceptible individuals. One such modifica-
tion that creates novel epitopes might be the citrullination
of an as yet undefined RA-specific autoantigen.
Rheumatoid arthritis autoantibodies and
citrullinated substrates
RA is diagnosed primarily on clinical disease manisfesta-
tions, and serological supporting evidence has, up to now,
been restricted to the determination of IgM rheumatoid
factor. This antibody occurs, however, in many inflamma-
tory diseases and in healthy elderly individuals. One
RA-specific autoantibody that has been characterized rea-
sonably well is the antiperinuclear factor, which was
described in 1964 by two Dutch scientists [5]. During the
past decade it has been shown convincingly that the peri-
nuclear factor is identical to filaggrin [6,7]. Filaggrin (fila-
ment-aggregating protein) is produced during the late
stages of terminal differentiation of epithelial cells in
mammals, and is synthesized as a heavily phosphorylated
precursor protein (profilaggrin) that consists of 10–12
homologous, but not identical filaggrin repeats. These
repeats are released by proteolytic cleavage during differ-
entiation of the cells. During this process, which resem-
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differentiated epithelial cells are dead cells, the filaggrin
polypeptides are dephosphorylated and about 20% of the
arginines are citrullinated by the enzyme PAD (Fig. 1). This
process also occurs in cells of the stratum corneum of the
oesophagus, and this explains why autoantibodies in RA
also stain this tissue in the so-called anti-keratin antibody
(AKA) test. The AKA test, which is less sensitive than the
antiperinuclear factor test, thus depends on the same sub-
strate – filaggrin [8].
It has recently been shown [7,9] that citrullinated residues
are essential parts of the antigenic determinants recognized
by autoantibodies that are present in RA patients. Using a
selected set of citrullinated peptides in an enzyme-linked
immunosorbent assay, a sensitivity of more than 70% and
an impressive specificity of better than 96% was obtained
[7,10]. In an early arthritis clinic study in Leiden, The Nether-
lands, [10] (Visser H et al, unpublished data), it was shown
that these anti-citrullinated peptide antibodies can be
present very early in disease, and, because of their extreme
specificity, they have the potential to become one of the cri-
teria for the early diagnosis of RA. Masson-Bessière et al
[11] have recently shown that these anticitrullinated protein
antibodies are locally produced by plasma cells in the syn-
ovium, and thus are likely to be triggered by a citrullinated
substrate that is present in the RA synovium. At a recent
workshop organized by Panayi at Oxford, UK [12], the same
group presented the very interesting and intriguing finding
that the a and b chains of fibrin are major citrullinated pro-
teins in the inflamed synovial tissue. This important finding
opens new and fascinating possibilities for study of the aeti-
ology of this enigmatic disease.
Citrullination
The process of citrullination in mammalian cells has been
studied by only a few groups, and involves the enzymatic
conversion (deimination) of protein-contained arginine
residues (Fig. 1). The result of this conversion is a very
small change in molecular mass (somewhat less than
1 Da) and the loss of one positive charge. The conse-
quence of the latter might be a change (loss or gain) in its
ability to interact with neighbouring proteins [13]. The
enzyme responsible for the citrullination is PAD. Today
several different human PAD enzymes (at least five) have
been identified, but not much is known about their tissue
distribution, their cellular localization, and how and when
these enzymes are activated. Very interesting in the
context of autoimmunity is the finding that PAD activity (ie
PAD mRNA levels) appears to be strongly influenced by a
variety of oestrogenic compounds [14,15].
At present there are only a few citrullinated proteins known in
mammalian cells. It is unlikely that one of these (ie myelin
basic protein, filaggrin and trychohyalin) would be the citrulli-
nated RA-specific autoantigen, because none of these pro-
teins appears to be present in, for example, synovial tissue.
Therefore, it seems misleading to refer to these autoantibod-
ies as antifilaggrin antibodies [11]. We propose to name
them anticitrullinated protein antibodies, because it is very
likely that many more citrullinated proteins exist, including in
the synovium, as has recently been shown [12]. An intriguing
possibility is that some proteins may become citrullinated
under pathological conditions, as might be the case for fibrin
in the synovial tissue [12]. It is also interesting to note that
during apoptosis some cellular proteins become citrullinated.
Apoptosis and autoantigen modification
During apoptosis the morphology of the cell changes dra-
matically. Membrane ruffling occurs, followed by the forma-
tion of apoptotic blebs, cytoplasmic and organelle
condensation/shrinkage, and nuclear contraction. The
resulting cellular fragments, or apoptotic bodies, under
normal circumstances are subject to rapid receptor-medi-
ated ingestion by neighbouring cells and resident tissue
phagocytes. In a widely cited publication [16] the group of
Rosen showed that many nuclear and cytoplasmic autoanti-
gens translocate to the membrane and can be detected in
the large and small apoptotic blebs. It has also been shown
[4] that such autoantigens often are modified by cleavage,
(de)phosphorylation, ubiquitination or cross-linking. Citrulli-
nation of cellular proteins also occurs during apoptosis
[17,18]. In particular the apoptotic citrullination of vimentin
[17] is interesting because such modifications may con-
tribute to the morphological changes of the apoptotic cell.
The citrullination lowers the positive charge of the protein
(Fig. 1), which may lead to a destabilization or even loss of
intermolecular and intramolecular interactions. In the case of
vimentin filaments, citrullination can induce almost complete
depolymerization, disrupting the cytoskeletal network [19].
Apoptosis, citrullination and rheumatoid
arthritis
Although the presence of apoptotic cells in, for example,
synovial tissue is not obvious [20], it is possible that
Figure 1
The enzymatic conversion of protein-contained arginine to citrulline.
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environmental factors (including pathogenic processes)
may locally induce abnormal cell death or disturb the
clearance of apoptotic cells. Subsequently, citrullinated
(or otherwise modified) protein fragments may be pre-
sented to the immune system. We postulate that such
modifications may take place only at certain sites in the
body, and thus represent unique epitopes to which no
effective tolerance exists. A primary and specific immune
response will then develop. The resulting autoantibodies
will recognize epitopes on apoptotic cells that express
autoantigenic molecules at the cell surface, and such
opsonized apoptotic cells will generate further proinflam-
matory responses, and finally induce epitope spreading to
nonmodified regions of the autoantigen(s).
Conclusion
Many more studies on apoptosis in pathological condi-
tions are necessary to prove or refute the hypothesis pre-
sented above. We know that autoimmunity in general is
influenced strongly by genetic, hormonal and environmen-
tal factors. The control of apoptosis and the regulation of
the immunological processes (the quality of the
self–nonself discrimination) are very much dependent on
the genetic load of the patient. The fact that autoimmune
diseases occur much more frequently in women is a clear
indication that sex hormones play an important role. Inter-
estingly, the activity of citrullinating enzymes (PAD)
appears to be dependent on hormonal influences. Finally,
it has been shown repeatedly that environmental factors
(eg viral/bacterial infections) may lead to enhanced cyto-
toxic T lymphocyte-induced apoptosis, and that apoptotic
cell fragments can be processed and presented by den-
dritic cells. It is also evident that citrullination occurs in
dying cells and that citrullinated antigens are specifically
recognized by autoantibodies in RA patients.
What we need to show is that citrullination of relevant self-
proteins induces the production of autoantibodies. Such
studies may also shed light on whether anticitrullinated
peptide antibodies have pathological effects.
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